This is consistent with previous reports that SEMA3F forms a complex with NRP2 and PLXNA1 within 5 min upon treatment on human glioma cells (34) and induced the reduction in phosphorylation of downstream signaling molecules between 5 and 20 min (25). The gene discussed is NRP2; the disease is central nervous system cancer.